DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells
- PMID: 17283169
- DOI: 10.1158/0008-5472.CAN-06-2264
DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells
Abstract
Although natural killer (NK) cells are well known for their ability to kill tumors, few studies have addressed the interactions between resting (nonactivated) NK cells and freshly isolated human tumors. Here, we show that human leukocyte antigen class I(low) tumor cells isolated directly from patients with advanced ovarian carcinoma trigger degranulation by resting allogeneic NK cells. This was paralleled by induction of granzyme B and caspase-6 activities in the tumor cells and significant tumor cell lysis. Ovarian carcinoma cells displayed ubiquitous expression of the DNAX accessory molecule-1 (DNAM-1) ligand PVR and sparse/heterogeneous expression of the NKG2D ligands MICA/MICB and ULBP1, ULBP2, and ULBP3. In line with the NK receptor ligand expression profiles, antibody-mediated blockade of activating receptor pathways revealed a dominant role for DNAM-1 and a complementary contribution of NKG2D signaling in tumor cell recognition. These results show that resting NK cells are capable of directly recognizing freshly isolated human tumor cells and identify ovarian carcinoma as a potential target for adoptive NK cell-based immunotherapy.
Similar articles
-
Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.Cancer Res. 2005 Jul 15;65(14):6321-9. doi: 10.1158/0008-5472.CAN-04-4252. Cancer Res. 2005. PMID: 16024634
-
NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways.Mol Immunol. 2008 Sep;45(15):3917-25. doi: 10.1016/j.molimm.2008.06.016. Epub 2008 Jul 26. Mol Immunol. 2008. PMID: 18657862
-
The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.Cancer Res. 2007 Sep 15;67(18):8444-9. doi: 10.1158/0008-5472.CAN-06-4230. Cancer Res. 2007. PMID: 17875681
-
NK cell recognition and killing of melanoma cells is controlled by multiple activating receptor-ligand interactions.J Innate Immun. 2011;3(4):365-73. doi: 10.1159/000328505. Epub 2011 May 11. J Innate Immun. 2011. PMID: 21576932 Review.
-
The NKG2D receptor: sensing stressed cells.Trends Mol Med. 2008 Apr;14(4):179-89. doi: 10.1016/j.molmed.2008.02.004. Epub 2008 Mar 18. Trends Mol Med. 2008. PMID: 18353724 Review.
Cited by
-
Blockade of the immunosuppressive KIR2DL5/PVR pathway elicits potent human NK cell-mediated antitumor immunity.J Clin Invest. 2022 Nov 15;132(22):e163620. doi: 10.1172/JCI163620. J Clin Invest. 2022. PMID: 36377656 Free PMC article.
-
Multi-omics characterization of silent and productive HPV integration in cervical cancer.Cell Genom. 2023 Jan 11;3(1):100211. doi: 10.1016/j.xgen.2022.100211. eCollection 2023 Jan 11. Cell Genom. 2023. PMID: 36777180 Free PMC article.
-
Regulation of human NK-cell cytokine and chemokine production by target cell recognition.Blood. 2010 Mar 18;115(11):2167-76. doi: 10.1182/blood-2009-08-238469. Epub 2009 Dec 1. Blood. 2010. PMID: 19965656 Free PMC article.
-
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27.Oncotarget. 2017 May 23;8(21):35088-35102. doi: 10.18632/oncotarget.17070. Oncotarget. 2017. PMID: 28456791 Free PMC article.
-
Fcγ receptor-mediated cross-linking codefines the immunostimulatory activity of anti-human CD96 antibodies.JCI Insight. 2022 Oct 10;7(19):e158444. doi: 10.1172/jci.insight.158444. JCI Insight. 2022. PMID: 35998045 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials